Call in to speak with the host
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer Institute and BROAD Institue recently published an article in Cancer Cell describing the complexity and what it means for myeloma patients.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.